For weight loss specifically, Wegovy (the obesity-indication brand of semaglutide) follows a similar but slightly different schedule, titrating up to 2.4 mg
Proceedings of the National Academy of Sciences 118 (34): e2025813118
Unlike semaglutide, which targets only GLP-1 receptors, tirzepatide is a dual agonist it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously
Marcello M, Virz GM, Marturano D, de Cal M, Marchionna N, Sgarabotto L, et al
Tips to Reduce Nausea: Have smaller meals : Eating too much can make things worse
Each of these sites contains adequate subcutaneous tissuethe layer of fat beneath the skinwhich allows for proper absorption of the medication into the bloodstream